C12N 2501/05
Adjuvants
C12N2501/05 (Adjuvants) appears on 110 US grants and 246 published applications in this corpus.
Search patents in C12N- Granted patents
- 110
- Published applications
- 246
- Assignees
- 182
- Inventors
- 532
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 4 |
| 2004 | 0 | 11 |
| 2005 | 1 | 5 |
| 2006 | 0 | 7 |
| 2007 | 2 | 8 |
| 2008 | 3 | 6 |
| 2009 | 3 | 4 |
| 2010 | 3 | 11 |
| 2011 | 8 | 7 |
| 2012 | 9 | 9 |
| 2013 | 3 | 9 |
| 2014 | 5 | 7 |
| 2015 | 0 | 13 |
| 2016 | 12 | 13 |
| 2017 | 9 | 16 |
| 2018 | 6 | 12 |
| 2019 | 5 | 14 |
| 2020 | 3 | 18 |
| 2021 | 6 | 13 |
| 2022 | 6 | 12 |
| 2023 | 7 | 9 |
| 2024 | 5 | 20 |
| 2025 | 4 | 12 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof25 Aug 2026US 12,716,055 B2Fibrobiologics, Inc.
- Method for increasing dendritic cell migration ability, and use thereof14 Apr 2026US 12,600,946 B2Cha University Industry-Academic Cooperation Foundation
- Bone marrow microglia progenitor cells and uses thereof7 Apr 2026US 12,594,305 B2Strominnate Therapeutics AB
- Method for the in vitro differentiation and maturation of dendritic cells for therapeutic use24 Feb 2026US 12,559,535 B2Universiteit Gent
- Delivery of biomolecules to immune cells9 Sep 2025US 12,410,392 B2Massachusetts Institute of Technology
- Enrichment and expansion of chimeric antigen receptor t cells using antigen-presenting biomaterials1 Oct 2026US 2026/0297520 A1The Regents of the University of California
- Method of evaluating intercellular interactions in neuroinflammation30 Apr 2026US 2026/0118345 A1FUJIFILM Corporation
- Method to change the polarization of tumor associated macrophages by exposing them to a source of radiation in the presence of magnetosomes9 Apr 2026US 2026/0097075 A1Centre National De La Recherche Scientifique
- Cell system and application thereof, and method for activating broad-spectrum cancer cell-specific t cell18 Dec 2025US 2025/0381271 A1Suzhou Ersheng Biomedical Co., Ltd.
- Macrophage-derived engineered vesicles for targeted delivery and treatment13 Nov 2025US 2025/0345283 A1University of Kentucky Research Foundation
Most cited
By later US patents
- Immunostimulatory nucleic acid molecules for activating dendritic cells265US 6,429,199 B1University of Iowa Research Foundation · 2002
- Methods related to immunostimulatory nucleic acid-induced interferon110US 6,949,520 B1Coley Pharmaceutical GmbH · 2005
- Method for proliferation of antigen-specific T cells54US 9,476,028 B2Immunicum AB · 2016
- Methods related to immunostimulatory nucleic acid-induced interferon42US 7,776,344 B2Coley Pharmaceutical GmbH · 2010
- Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications38US 6,165,785 AShriners Hospitals for Children · 2000